ImmuneBiotech Medical Sweden AB Strengthens Leadership with Strategic Appointment of Rickard Mosell as Chairman of the Board
Press Release Lund, Sweden, October 14, 2024 ImmuneBiotech, [...]
ImmuneBiotech Medical Sweden AB announces the appointment of international microbiome expert Kristin Wannerberger to board of directors
Press Release Lund, Sweden, May 11, 2023 [...]
ImmuneBiotech closes fully subscribed new share issue with funding from recognized investors and existing shareholders
Press Release Lund, Sweden, January 20 2021 [...]
ImmuneBiotech: Patent granted for GutMagnific® in the United States
Press Release Lund, Sweden, October 16 2019 [...]
ImmuneBiotech: starts clinical trial of GutMagnific® in ME/CFS in collaboration with Stora Sköndal ME clinic
Press Release Lund, Sweden, June 10 2020 [...]
ImmuneBiotech: market launch of first product GutMagnific
Press Release Lund, Sweden, October 16 2019 [...]
ImmuneBiotech: Winner of H2020 “SME Instrument” Phase 1
Press Release Lund, Sweden, May 7 2019 [...]
ImmuneBiotech closes new share issue with funding from recognized international investors and business angels
Press Release Lund, Sweden, January 24, 201 [...]